Keyphrases
Squamous Cell
100%
Protease-activated Receptor 2 (PAR2)
100%
Oncogenesis
100%
Nonhematopoietic
100%
Malignant Progression
100%
Matriptase
100%
Potentiation
100%
Inflammatory Pathways
18%
Pro-tumorigenic
18%
Protease
18%
Epistasis Analysis
9%
Human Carcinoma
9%
Inflammatory Cell Infiltration
9%
Genetic Epistasis
9%
Cytokine Production
9%
Cell-based
9%
Epidermal Hyperplasia
9%
Tumor-associated
9%
Membrane-anchored Serine Protease
9%
Cellular Expression
9%
Nuclear factor-B
9%
Malignant Transformation
9%
Proliferative Signaling
9%
Poor Prognosis
9%
Epithelial Stem Cells
9%
Dysregulated
9%
AKT1
9%
Bone Marrow Cells
9%
Inflammatory Cytokines
9%
Mammalian Target of Rapamycin (mTOR)
9%
Epithelial Carcinogenesis
9%
Medicine and Dentistry
Squamous Cell
100%
Proteinase Activated Receptor 2
100%
Carcinogenesis
100%
Matriptase
100%
Ras Signaling
100%
Stem Cell
18%
Proteinase
18%
Neoplasm
9%
Alternative Complement Pathway C3 C5 Convertase
9%
Carcinoma
9%
Malignant Transformation
9%
Protein Kinase B
9%
Inflammatory Cytokine
9%
Cytokine Production
9%
Serine Proteinase
9%
Inflammatory Cell
9%
Epistasis
9%
Epidermis Hyperplasia
9%
Nuclear Factor
9%
Keratinocyte
9%
Skin Fibrosis
9%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
100%
Protease-Activated Receptor 2
100%
Matriptase
100%
Protease
18%
Stem Cell
18%
Keratinocyte
9%
Malignant Transformation
9%
Epistasis
9%
Cytokine Production
9%
Inflammatory Cytokine
9%
Complement Factor B
9%
Serine Protease
9%
Genetics
9%
Protein Kinase B
9%